ICIs, by blocking the PD1-PD-L1 and the CD86/CTLA4 axes, prevent tumor cells from releasing wrong messages to T cells, thereby restoring tumor-induced immuno-deficiency in TIME (38). The gene discussed is CD86; the disease is neoplasm.